Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
Clinical trial NCT06941025 · RECRUITING
Trial details
- NCT number
- NCT06941025
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-23
- Primary completion
- 2034-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.